These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 32716129)
1. Inflammatory myofibroblastic tumor arising from soft tissues of extremities harboring a novel CLIP2-ALK fusion. Ding R; Li X; Zhu XM; Song QX; Fan QH; Zhang ZH; Gong QX Pathol Int; 2020 Oct; 70(10):798-803. PubMed ID: 32716129 [TBL] [Abstract][Full Text] [Related]
2. [Clinicopathological features of inflammatory myofibroblastic tumor]. Zhu Y; Ding Y; Song GX; Li X; Ding R; Fan QH; Gong QX Zhonghua Bing Li Xue Za Zhi; 2021 Mar; 50(3):194-200. PubMed ID: 33677881 [No Abstract] [Full Text] [Related]
3. Anaplastic lymphoma kinase-negative uterine inflammatory myofibroblastic tumor containing the ETV6-NTRK3 fusion gene: a case report. Takahashi A; Kurosawa M; Uemura M; Kitazawa J; Hayashi Y J Int Med Res; 2018 Aug; 46(8):3498-3503. PubMed ID: 29900760 [TBL] [Abstract][Full Text] [Related]
4. Pregnancy-associated Inflammatory Myofibroblastic Tumors of the Uterus Are Clinically Distinct and Highly Enriched for TIMP3-ALK and THBS1-ALK Fusions. Devereaux KA; Fitzpatrick MB; Hartinger S; Jones C; Kunder CA; Longacre TA Am J Surg Pathol; 2020 Jul; 44(7):970-981. PubMed ID: 32271187 [TBL] [Abstract][Full Text] [Related]
5. Inflammatory myofibroblastic tumor and low-grade myofibroblastic sarcoma: a comparative study of clinicopathologic features and further observations on the immunohistochemical profile of myofibroblasts. Qiu X; Montgomery E; Sun B Hum Pathol; 2008 Jun; 39(6):846-56. PubMed ID: 18400254 [TBL] [Abstract][Full Text] [Related]
6. Uterine inflammatory myofibroblastic tumor: First report of a ROS1 fusion. Bennett JA; Wang P; Wanjari P; Diaz L; Oliva E Genes Chromosomes Cancer; 2021 Dec; 60(12):822-826. PubMed ID: 34322931 [TBL] [Abstract][Full Text] [Related]
8. Superficial ALK-rearranged myxoid spindle cell neoplasm: a cutaneous soft tissue tumor with distinctive morphology and immunophenotypic profile. Dermawan JK; Azzato EM; Goldblum JR; Rubin BP; Billings SD; Ko JS Mod Pathol; 2021 Sep; 34(9):1710-1718. PubMed ID: 34088997 [TBL] [Abstract][Full Text] [Related]
9. A novel LRRFIP1-ALK fusion in inflammatory myofibroblastic tumor of hip and response to crizotinib. Liu W; Duan Q; Gong L; Yang Y; Huang Z; Guo H; Niu X Invest New Drugs; 2021 Feb; 39(1):278-282. PubMed ID: 32915420 [TBL] [Abstract][Full Text] [Related]
10. A novel fusion of HNRNPA1-ALK in inflammatory myofibroblastic tumor of urinary bladder. Inamura K; Kobayashi M; Nagano H; Sugiura Y; Ogawa M; Masuda H; Yonese J; Ishikawa Y Hum Pathol; 2017 Nov; 69():96-100. PubMed ID: 28504207 [TBL] [Abstract][Full Text] [Related]
11. ALK Immunoexpression is Specific for Inflammatory Myofibroblastic Tumor Among Vulvovaginal Mesenchymal Neoplasms. Bowman CJ; Medeiros F; Fadare O; Sangoi AR; Horvai AE; Devine WP; McCluggage WG; Rabban JT Int J Gynecol Pathol; 2023 Jan; 42(1):1-10. PubMed ID: 35180768 [TBL] [Abstract][Full Text] [Related]
12. Uterine Inflammatory Myofibroblastic Tumor Showing an Atypical ALK Signal Pattern by FISH and DES-ALK Fusion by RNA Sequencing: A Case Report. Zarei S; Abdul-Karim FW; Chase DM; Astbury C; Policarpio-Nicolas MLC Int J Gynecol Pathol; 2020 Mar; 39(2):152-156. PubMed ID: 30741845 [TBL] [Abstract][Full Text] [Related]
13. The Presence of ALK Alterations and Clinical Relevance of Crizotinib Treatment in Pediatric Solid Tumors. Felkai L; Bánusz R; Kovalszky I; Sápi Z; Garami M; Papp G; Karászi K; Varga E; Csóka M Pathol Oncol Res; 2019 Jan; 25(1):217-224. PubMed ID: 29081033 [TBL] [Abstract][Full Text] [Related]
15. Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases. Cessna MH; Zhou H; Sanger WG; Perkins SL; Tripp S; Pickering D; Daines C; Coffin CM Mod Pathol; 2002 Sep; 15(9):931-8. PubMed ID: 12218210 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic and Genomic Characterization of Inflammatory Myofibroblastic Tumors of the Head and Neck: Highlighting a Novel Fusion and Potential Diagnostic Pitfall. Kerr DA; Thompson LDR; Tafe LJ; Jo VY; Neyaz A; Divakar P; Paydarfar JA; Pastel DA; Shirai K; John I; Seethala RR; Salgado CM; Deshpande V; Bridge JA; Kashofer K; Brčić I; Linos K Am J Surg Pathol; 2021 Dec; 45(12):1707-1719. PubMed ID: 34001695 [TBL] [Abstract][Full Text] [Related]
17. Uterine inflammatory myofibroblastic tumors in pregnant women with and without involvement of the placenta: a study of 6 cases with identification of a novel TIMP3-RET fusion. Cheek EH; Fadra N; Jackson RA; Davila JI; Sukov WR; Uckerman MT; Clayton A; Keeney GL; Halling KC; Torres-Mora J; Schoolmeester JK Hum Pathol; 2020 Mar; 97():29-39. PubMed ID: 31917155 [TBL] [Abstract][Full Text] [Related]
18. Two cases of inflammatory myofibroblastic tumor treated with targeted drugs: A case report. Liu M; Zhu D Medicine (Baltimore); 2024 May; 103(21):e38136. PubMed ID: 38787978 [TBL] [Abstract][Full Text] [Related]
19. Rare presentation of inflammatory myofibroblastic tumor on a digit. West CE; Workman A; Moody T; Hosler GA J Cutan Pathol; 2021 Jul; 48(7):965-968. PubMed ID: 33754372 [TBL] [Abstract][Full Text] [Related]
20. Identification of CARS-ALK fusion in primary and metastatic lesions of an inflammatory myofibroblastic tumor. Debelenko LV; Arthur DC; Pack SD; Helman LJ; Schrump DS; Tsokos M Lab Invest; 2003 Sep; 83(9):1255-65. PubMed ID: 13679433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]